
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $656.8M | -- | -- | $2.64 | -- |
07/31/2025 | Q2 | $651.4M | -- | -- | $2.69 | -- |
04/30/2025 | Q1 | $515.9M | $504.9M | $0.59 | $1.67 | -$1.08 |
02/19/2025 | Q4 | $864.5M | $882.2M | $3.21 | $3.86 | -$0.65 |
11/06/2024 | Q3 | $523.9M | $601.9M | $1.46 | $1.73 | -$0.27 |
07/31/2024 | Q2 | $555.8M | $594.1M | $1.48 | $1.94 | -$0.46 |
05/01/2024 | Q1 | $555M | $466.6M | $0.40 | $1.98 | -$1.58 |
02/21/2024 | Q4 | $795.9M | $805.1M | $3.15 | $3.70 | -$0.55 |
11/01/2023 | Q3 | -- | -- | $0.64 | $1.27 | -$0.63 |
08/02/2023 | Q2 | -- | -- | $0.80 | $1.52 | -$0.72 |
05/03/2023 | Q1 | -- | -- | $1.15 | $1.61 | -$0.46 |
02/22/2023 | Q4 | -- | -- | $2.95 | $2.80 | $0.15 |
11/02/2022 | Q3 | -- | -- | $1.10 | $1.65 | -$0.55 |
08/03/2022 | Q2 | -- | -- | $1.13 | $1.61 | -$0.48 |
05/04/2022 | Q1 | -- | -- | $0.81 | $1.16 | -$0.35 |
02/23/2022 | Q4 | -- | -- | $2.30 | $2.72 | -$0.42 |
11/03/2021 | Q3 | -- | -- | $0.97 | $1.35 | -$0.38 |
08/04/2021 | Q2 | -- | -- | $1.06 | $1.56 | -$0.50 |
05/05/2021 | Q1 | -- | -- | $0.82 | $0.84 | -$0.02 |
02/24/2021 | Q4 | -- | -- | $2.46 | $2.55 | -$0.09 |
11/04/2020 | Q3 | -- | -- | $0.87 | $1.26 | -$0.39 |
08/05/2020 | Q2 | -- | -- | $1.11 | $1.16 | -$0.05 |
05/06/2020 | Q1 | -- | -- | $0.53 | $0.79 | -$0.26 |
02/26/2020 | Q4 | -- | -- | $1.91 | $1.99 | -$0.08 |
11/06/2019 | Q3 | -- | -- | $1.04 | $1.26 | -$0.22 |
08/05/2019 | Q2 | -- | -- | $1.61 | $1.28 | $0.33 |
05/01/2019 | Q1 | -- | -- | $1.29 | $1.09 | $0.20 |
02/27/2019 | Q4 | -- | -- | $2.13 | $1.45 | $0.68 |
11/07/2018 | Q3 | -- | -- | $1.31 | $1.06 | $0.25 |
08/06/2018 | Q2 | -- | -- | $1.35 | $1.10 | $0.25 |
05/02/2018 | Q1 | -- | -- | $1.20 | $1.04 | $0.16 |
02/22/2018 | Q4 | -- | -- | $1.07 | $1.03 | $0.04 |
11/01/2017 | Q3 | -- | -- | $1.05 | $0.97 | $0.08 |
08/02/2017 | Q2 | -- | -- | $0.99 | $0.91 | $0.08 |
05/03/2017 | Q1 | -- | -- | $0.89 | $0.83 | $0.06 |
02/23/2017 | Q4 | -- | -- | $0.92 | $0.90 | $0.02 |
11/03/2016 | Q3 | -- | -- | $0.88 | $0.85 | $0.03 |
08/04/2016 | Q2 | -- | -- | $0.87 | $0.83 | $0.04 |
05/05/2016 | Q1 | -- | -- | $0.72 | $0.69 | $0.03 |
02/25/2016 | Q4 | -- | -- | $0.85 | $0.80 | $0.05 |
11/05/2015 | Q3 | -- | -- | $0.83 | $0.80 | $0.03 |
Ansys reported $504.9M worth of top line sales in its most recent quarter.
Ansys announced earnings per share of $0.59 which represents a miss of analyst forecast a $1.67 per share.
Ansys reported $432.3M that represents $4.91 per share over the last quarter.
Ansys's earnings are forecast to grow from $6.55 per share to $10.28 per share next year representing an increase of 79.44%.
Ansys's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.